-
Your RFQ cart is empty!
Everolimus
Venkatasai is a leading provider of pharmaceutical reference standards, specializing in the supply of high-purity Everolimus reference materials. Our portfolio includes both pharmacopeial and non-pharmacopeial impurities, metabolites, stable isotope-labeled compounds, and nitrosamine derivatives (N-NO products). These reference standards play a crucial role in pharmaceutical R&D, aiding in formulation development, ANDA/DMF submissions, quality control, method validation, stability studies, and impurity profiling—including the identification and assessment of potentially genotoxic impurities.
Each Everolimus -related product is rigorously characterized and delivered with a detailed Certificate of Analysis (COA) and comprehensive analytical data to ensure regulatory compliance. Upon request, we also offer EP/USP traceable standards. To maintain the highest quality standards, all materials are subject to periodic re-testing and continuous quality monitoring.
Everolimus is a medication used to manage high blood pressure and chest pain. It acts as both an alpha- and beta-adrenergic receptor blocker, making it effective for treating hypertension, angina, and conditions involving excessive sympathetic nervous system activity.
Everolimus
Everolimus EP Impurity A
Everolimus EP Impurity B
Everolimus EP Impurity C
Everolimus EP Impurity D
Everolimus EP Impurity E
Everolimus EP Impurity F
Everolimus t-Butyldimethylsilyl Ether
Everolimus Ring-opening Impurity
OXO-Everolimus
Everolimus Isomer C
Prolyl Everolimus
30-O-Desmethyl Everolimus
Seco Everolimus B
Everolimus Impurity 1
Everolimus Impurity 2
Everolimus Impurity 3
Everolimus Impurity 4
Everolimus Impurity 5
Everolimus O-Ethyl Impurity
